Saturday, 19 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Company
Drug
Everest Medicines’ Nefecon Included in South Korea’s GIFT Program
January 19, 2025
Company
Deals
Haohai Bio Acquires Additional Stake in SZNIMO for Ophthalmic Expansion
July 4, 2025
Company
Drug
Hinova’s HP530S Accepted for NMPA Review as FAK Inhibitor for Solid Tumors
January 19, 2025
Company
AstraZeneca Reports Q4 and Full-Year 2022 Results with Strong Revenue Growth
January 19, 2025
Company
Drug
Qilu Pharmaceutical’s QLS12004 Gains Tacit Clinical Trial Approval
January 19, 2025
Company
Deals
Sino Biopharmaceutical Terminates IPO Pre-Listing Process for STAR Board
January 19, 2025
Company
Deals
Shanghai Pinnacles Partners with Sysmex for Biochemical Immune Diagnosis Solutions
January 19, 2025
Company
Deals
GenScript ProBio Partners with Bio Immunitas for hRPP Platform
January 19, 2025
Company
Drug
ImmVira’s MVR-T3011 IT Shows Efficacy in Melanoma Treatment
June 26, 2025
Company
Deals
Hemay Pharma Completes Series D Financing for Autoimmune and Oncology Drugs
January 19, 2025
Company
Deals
Neurodawn Completes Series A+ Financing for CNS Drug Development
January 19, 2025
Company
Drug
Grand Pharma Completes Patient Enrollment for STC3141 Sepsis Study
January 19, 2025
1
2
…
1,034
1,035
1,036
1,037
1,038
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?